Benicar MDL Cases Survive Daiichi's Symptom Challenges

By Jeannie O'Sullivan ( April 18, 2016, 10:40 PM EDT) -- A New Jersey federal judge on Monday declined drugmaker Daiichi Sankyo Inc.'s efforts to boot cases from centralized litigation over the blood pressure drug Benicar with allegedly tenuous connections between consumers' gastrointestinal problems and the medication, finding that he couldn't fault patients who might be misinterpreting their symptoms....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!